Back to search

Improved Outcome of Allogeneic Transplantation in High-Risk Multiple Myeloma Patients After Nonmyeloablative Conditioning

Data up to Jan 2025

Published2002
Citations186
References22

Total Citations Per Year

Abstract

References (22)

A PROSPECTIVE, RANDOMIZED TRIAL OF AUTOLOGOUS BONE MARROW TRANSPLANTATION AND CHEMOTHERAPY IN MULTIPLE MYELOMA

2013 • 2,176 citations

Allogeneic Bone Marrow Transplantation in Multiple Myeloma

1991 • 389 citations

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation

1996 • 376 citations

Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities

2000 • 333 citations

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study

2000 • 317 citations

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.

1995 • 301 citations

Donor Lymphocyte Infusions for Relapsed Multiple Myeloma After Allogeneic Stem-Cell Transplantation: Predictive Factors for Response and Long-Term Outcome

2000 • 299 citations

Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic Cells

1999 • 253 citations

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

2001 • 196 citations

Molecular Remission After Allogeneic or Autologous Transplantation of Hematopoietic Stem Cells for Multiple Myeloma

2000 • 173 citations

Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells

2001 • 133 citations

Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease

2001 • 102 citations

Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma

2000 • 102 citations

Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation

2000 • 67 citations

Evaluation of an Automated Technique for Assessment of Marrow Engraftment After Allogeneic Bone Marrow Transplantation Using a Commercially Available Kit

2000 • 41 citations

Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support

2000 • 26 citations

Allogeneic Haemopoietic Stem Cell Transplantation for Multiple Myeloma or Plasma Cell Leukaemia Using Fractionated Total Body Radiation and High-dose Melphalan Conditioning

2000 • 26 citations

Distinct T-cell clonal expansion in the vicinity of tumor cells in plasmacytoma

2001 • 24 citations

Myeloma‐reactive allospecific cytotoxic T lymphocytes lyse target cells via the granule exocytosis pathway

2001 • 19 citations

Allogeneic bone marrow transplantation for the treatment of multiple myeloma: An overview of published reports

1996 • 19 citations

Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells

2000 • 13 citations

Allogeneic Peripheral Blood Stem Cell Transplantation for Hematologic Diseases

1999 • 3 citations

Cited By (0)

Loading...
Improved Outcome of Allogeneic Transplantation in High-Risk Multiple Myeloma Patients… (2002) – Journal of Clinical Oncology | Metascience Observatory Explorer